日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pilot study of ABO-isogroup or universal plasma pools with or without pathogen reduction treatment

ABO同血型或通用血浆池(含或不含病原体灭活处理)的试点研究

Cognasse, Fabrice; Duchez, Anne-Claire; Heestermans, Marco; Eyraud, Marie-Ange; Arthaud, Charles-Antoine; Prier, Amélie; Paul, Stéphane; Berger, Anne-Emmanuelle; Schaal, Orianne; Acquart, Sophie; Bruot, Betty; Gress, Sabrina; Belcour, Béatrice; Rochette-Eribon, Sandrine; Chavarin, Patricia; Hamzeh-Cognasse, Hind

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.

康复血浆治疗 COVID 的炎症特征:阿莫托沙林/UVA 病原体减少技术的影响

Cognasse Fabrice, Hamzeh-Cognasse Hind, Duchez Anne-Claire, Shurko Natalia, Eyraud Marie-Ange, Arthaud Charles-Antoine, Prier Amélie, Heestermans Marco, Hequet Olivier, Bonneaudeau Brigitte, Rochette-Eribon Sandrine, Teyssier Françoise, Barlet-Excoffier Valérie, Chavarin Patricia, Legrand Dominique, Richard Pascale, Morel Pascal, Mooney Nuala, Tiberghien Pierre